When does an advantage become unfair? Empirical and normative concerns in Semenya’s case

There is a fundamental tension in many sports: human sex is not binary, but there are only two categories in which people can compete: male and female. Over the past 10 years, the International Association of Athletics Federations (IAAF) regulations have been at the centre of two notable legal disputes. The Court of Arbitration for Sport (CAS) reached two contradictory rulings: in the first case (Dutee Chand vs Athletics Federation India and IAAF), the IAAF regulations for the eligibility of athletes to compete in the female category were suspended (24 July 2015) on grounds of "discrimination against the female category"; in the latter (Caster Semenya and Athletics South Africa vs IAAF), the regulations were reaffirmed (1 May 2019) on grounds that although discriminatory, they are necessary to maintain a "level playing field" and to “protect” the female category. Although Semenya’s case has paved the way for questioning existing gender norms in sport, a new stable norm has yet to emerge from her case. The pharmacological solution put forward by IAAF to the tension between fairness and inclusivity of bodies non-conforming to two sexes is not, however, the only possible solution/resolution to the case, as I aim to show in this paper. Here I present some reflections on this topic and suggest how CAS should approach the case if it hopes to resolve it.

[1]  L. Anderson,et al.  Transwomen in elite sport: scientific and ethical considerations , 2019, Journal of Medical Ethics.

[2]  A. Bianchi Something’s Got to Give: Reconsidering the Justification for a Gender Divide in Sport , 2019, Philosophies.

[3]  R. Pielke,et al.  Scientific integrity and the IAAF testosterone regulations , 2019, The International Sports Law Journal.

[4]  M. McNamee,et al.  Bioethics, Genetics and Sport , 2018 .

[5]  S. Camporesi,et al.  What statistical data of observational performance can tell us and what they cannot: the case of Dutee Chand v. AFI & IAAF , 2018, British Journal of Sports Medicine.

[6]  M. Ferguson-Smith,et al.  Hyperandrogenism controversy in elite women’s sport: an examination and critique of recent evidence , 2018, British Journal of Sports Medicine.

[7]  Stéphane Bermon,et al.  Serum androgen levels and their relation to performance in track and field: mass spectrometry results from 2127 observations in male and female elite athletes , 2017, British Journal of Sports Medicine.

[8]  A. Bianchi Transgender women in sport , 2017 .

[9]  Maayan Sudai The testosterone rule—constructing fairness in professional sport , 2017, Journal of law and the biosciences.

[10]  S. Camporesi Ethics of Regulating Competition for Women with Hyperandrogenism. , 2016, Clinics in sports medicine.

[11]  Sandy Montañola,et al.  Gender testing in sport: Ethics, cases and controversies , 2016 .

[12]  A. Olivesi From the Implicit to Aporia: the specificities of the Caster Semenya case as a "discursive moment" , 2016 .

[13]  R. Scott,et al.  Genomics of elite sporting performance: what little we know and necessary advances , 2013, British Journal of Sports Medicine.

[14]  Cheryl Cooky,et al.  Policing the Boundaries of Sex: A Critical Examination of Gender Verification and the Caster Semenya Controversy , 2013, Journal of sex research.

[15]  M. Hämäläinen The Concept of Advantage in Sport , 2012 .

[16]  V. Heggie Testing sex and gender in sports; reinventing, reimagining and reconstructing histories , 2010, Endeavour.

[17]  J. Savulescu,et al.  Time to re-evaluate gender segregation in athletics? , 2010, British Journal of Sports Medicine.

[18]  S. Perrotta,et al.  EPO Receptor Gain-of-Function Causes Hereditary Polycythemia, Alters CD34+ Cell Differentiation and Increases Circulating Endothelial Precursors , 2010, PloS one.

[19]  S. Camporesi,et al.  Caster Semenya: sport, categories and the creative role of ethics , 2010, Journal of Medical Ethics.

[20]  S. Loland,et al.  Fair Play in Sport: A Moral Norm System , 2001 .